about
Purification and characterization of the human elongator complexOTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitinParkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signalingMalt1 ubiquitination triggers NF-kappaB signaling upon T-cell activationCOP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulationDephosphorylation of Carma1 by PP2A negatively regulates T-cell activationThe E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMODistinct isocomplexes of the TRAPP trafficking factor coexist inside human cellsDegradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signalingNF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexesTissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomiaShared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalphaStructural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspaseActivity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomasThe let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2Controlling NF-kappaB activation in T cells by costimulatory receptorsNuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activityDlg3 trafficking and apical tight junction formation is regulated by nedd4 and nedd4-2 e3 ubiquitin ligasesYOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-κBOncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cellsNF-κB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-κB activationPharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1.Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanismCleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation.Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells.Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1.Inhibition of Canonical NF-κB Signaling by a Small Molecule Targeting NEMO-Ubiquitin InteractionDevelopment of new Malt1 inhibitors and probes.Mechanisms of NF-κB deregulation in lymphoid malignancies.A pervasive role of ubiquitin conjugation in activation and termination of IkappaB kinase pathways.Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome.Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.Ubiquitin Conjugation and Deconjugation in NF-κB Signaling.Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma.Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome.
P50
Q24291914-324F3A64-10B8-4B0E-9044-D2A4B98996DBQ24294696-2B5F2F25-582E-4C95-8F95-CD25FB725C6DQ24297849-48745227-9F47-43D5-98B0-3A84166AFE3EQ24298225-A15EF3B6-A34D-46F4-8E41-9055FBB06A7DQ24311222-18D89390-1030-4105-98D0-6D924F772CDBQ24316356-0FC88AA9-BD92-4B80-AC55-13D0D460F904Q24321825-5DE4458E-9250-41E1-BB96-7B0D275913EBQ24324380-45264473-3267-465C-95E0-E6521EA9C552Q24336767-C8432C5B-A338-4279-AED1-1EAA69201E34Q24534356-0FE6B15A-0AF0-4B1C-8AF4-44C74F57EA84Q24536194-FDE3BA62-B2D6-420B-8D46-C9B2CE10337DQ24548385-F60B81B7-2EA1-44BA-A401-D6081FED4AE5Q27685382-B7178C6F-615F-4413-883C-6A8530B275BEQ27697290-F585A0C4-355B-400E-94F9-73D888411662Q28264111-FB8865C3-B97C-47AA-B27C-73390770DEE0Q28291648-7A3B54BB-B3B0-4CC8-97D6-BB8D5E1BD67DQ28383134-4DF30C9A-EB15-414A-8951-1FD5C7A9CF3CQ28505178-8C423E56-F915-43C2-BC88-CDA17079FF2FQ30361285-42122791-412D-4720-AAD0-3C7415F48F25Q30375911-129738CC-D747-4903-8989-42C01EA0B4B2Q30385214-307CABA0-1723-49FC-BBCE-58196EDBF6A2Q33915312-6470D868-EF7C-42B2-950D-D80EA98788CDQ33958556-B44A7EBD-EC7A-4617-BDA3-E16F0727F667Q34015858-62636B7E-3D29-42E4-91AD-554831A647DCQ34227912-6CBA645B-C3F2-4497-9F9F-6EF66D8DBE4BQ34441762-4D3E587B-C645-417F-ACB6-68C61EB0E678Q34472091-13E3341E-7E4C-4CED-924A-A55BEE768ABFQ34521887-81144BD9-F4E8-4CD1-A389-739705D4BA05Q34624811-B555D63D-8301-414E-9231-C7FFC6B73116Q35126481-685E5D88-599C-4AE1-BC4D-28FD71C6F1A7Q35887748-D6588BC5-7932-48EC-8A0B-7DAD4446476EQ35991775-13A3C473-9195-45C9-884D-250581059212Q36041294-AE11658C-3013-4D7C-A85B-F03B52F17329Q36089051-6161F1EA-2587-447B-A2A8-9379A9C07E64Q36681767-668F8BCA-9E4D-4B8B-BFBD-3439BDA71AD5Q37683382-DA396D0E-DB28-41D9-A7AB-9238B0996D86Q37827466-1D9194DB-E9D4-4079-9152-55520BA61AB8Q38182355-C9B29297-4EC8-4580-BAC6-1E4FB2605F91Q38311898-44BE404E-1B86-48FE-86BD-EBA9D61A28A0Q38897903-0BAEA759-2C17-4C80-B161-60EB6ECBB86B
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Daniel Krappmann
@ast
Daniel Krappmann
@en
Daniel Krappmann
@es
Daniel Krappmann
@fr
Daniel Krappmann
@nl
Daniel Krappmann
@sl
type
label
Daniel Krappmann
@ast
Daniel Krappmann
@en
Daniel Krappmann
@es
Daniel Krappmann
@fr
Daniel Krappmann
@nl
Daniel Krappmann
@sl
prefLabel
Daniel Krappmann
@ast
Daniel Krappmann
@en
Daniel Krappmann
@es
Daniel Krappmann
@fr
Daniel Krappmann
@nl
Daniel Krappmann
@sl
P214
P106
P1153
6603676331
P21
P214
P31
P496
0000-0001-7640-3234
P735
P7859
viaf-18044964